Dipesh C Patel

Honorary Associate Professor

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dipesh C Patel is an Honorary Associate Professor at University College London,United Kingdom. His research focuses on the management of diabetes, particularly the role of SGLT2 inhibitors and GLP-1 receptor agonists in primary care. Recent articles highlight his contributions to understanding treatment paradigms and clinical practices surrounding diabetes and chronic kidney disease.

Articles (11)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Helen Parretti

Clinical Senior Lecturer

University of East Anglia

UNITED KINGDOM

View details

William David Strain

UNITED KINGDOM

View details

Parth Narendran

University of Birmingham

UNITED KINGDOM

View details

Benjamin Field

Clinical Reader in Diabetes and Endocrinology

University of Surrey

UNITED KINGDOM

View details

Emma G Wilmot

University of Nottingham School of Medicine

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dipesh C Patel

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

10 Top Tips for the Management of GLP-1 Receptor Agonists within Primary Care

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study.

Cushing[rdquo]s crises arising from a neuroendocrine tumour treated with etomidate infusion

Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently

The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review

Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021

New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice

A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives

Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review

Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

Collaborators (5)

Helen Parretti

William David Strain

Parth Narendran

Benjamin Field

Emma G Wilmot

Make your next move.